Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
PROCAINAMIDE HYDROCHLORIDE INJ. USP SANDOZ CANADA INCORPORATED Anticipated shortage 100MG New Report 2022-11-28 176066
SANDOZ POLYTRIMETHOPRIM SANDOZ CANADA INCORPORATED Anticipated shortage 1MG 10000UNIT New Report 2022-11-28 176062
SANDOZ MOMETASONE SANDOZ CANADA INCORPORATED Anticipated shortage 50MCG New Report 2022-11-28 176059
HYDROMORPHONE HYDROCHLORIDE INJECTION USP SANDOZ CANADA INCORPORATED Anticipated shortage 2MG New Report 2022-11-28 176056
SANDOZ CIPROFLOXACIN SANDOZ CANADA INCORPORATED Anticipated shortage 500MG New Report 2022-11-28 176052
SANDOZ CANDESARTAN SANDOZ CANADA INCORPORATED Anticipated shortage 16MG New Report 2022-11-28 176049
SANDOZ CANDESARTAN PLUS SANDOZ CANADA INCORPORATED Anticipated shortage 12.5MG 16MG New Report 2022-11-28 176046
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED Anticipated shortage 30MG New Report 2022-11-28 176042
TOBRAMYCIN INJECTION USP SANDOZ CANADA INCORPORATED Actual shortage 40MG Updated Report 2022-11-28 173388
SANDOZ TAMSULOSIN CR SANDOZ CANADA INCORPORATED Actual shortage 0.4MG Updated Report 2022-11-28 176003

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
PMS-FENTANYL MTX PHARMASCIENCE INC Discontinued 12MCG Updated Report 2022-11-25 165397
PMS-FENTANYL MTX PHARMASCIENCE INC Discontinued 12MCG Updated Report 2022-11-25 165462
HIBERIX GLAXOSMITHKLINE INC To be discontinued 10MCG New Report 2022-11-18 175258
!!T3 INTEGRILIN MERCK CANADA INC Discontinued 0.75MG Updated Report 2022-11-18 155790
!!T3 INTEGRILIN MERCK CANADA INC Discontinued 2MG Updated Report 2022-11-18 155794
DEXTROSE INJECTION USP ICU MEDICAL CANADA INC Discontinued 100MG Updated Report 2022-11-16 148657
3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE ICU MEDICAL CANADA INC Discontinued 3MG 33.3MG Updated Report 2022-11-16 148660
POTASSIUM CHLORIDE 20 MEQ IN 0.9% SODIUM CHLORIDE ICU MEDICAL CANADA INC Discontinued 0.9G 0.15G Updated Report 2022-11-16 148671
3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE ICU MEDICAL CANADA INC Discontinued 3MG 33.3MG Updated Report 2022-11-16 148651
POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE ICU MEDICAL CANADA INC Discontinued 0.3G 5G Updated Report 2022-11-16 148663
POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE ICU MEDICAL CANADA INC Discontinued 0.149G 0.45G 5G Updated Report 2022-11-16 148668
POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE ICU MEDICAL CANADA INC Discontinued 0.149G 5G Updated Report 2022-11-16 148654
HEPSERA GILEAD SCIENCES CANADA INC To be discontinued 10MG Updated Report 2022-11-14 171243
OXYTROL ALLERGAN INC Discontinued 3.9MG Updated Report 2022-11-14 172631
RAPAFLO ALLERGAN INC Discontinued 8MG Updated Report 2022-11-14 149531
PHARMA-AMLODIPINE PHARMASCIENCE INC Discontinued 10MG Updated Report 2022-11-12 174372
HUMULIN N ELI LILLY CANADA INC Discontinued 100UNIT Updated Report 2022-11-11 156217
AMERGE GLAXOSMITHKLINE INC To be discontinued 2.5MG Updated Report 2022-11-09 148430
PMS-AMOXICILLIN PHARMASCIENCE INC Discontinued 500MG New Report 2022-11-08 173976
TARO-WARFARIN TARO PHARMACEUTICALS INC Discontinued 7.5MG New Report 2022-11-04 173760